Results 151 to 160 of about 6,122,672 (198)

Versatility of the O-Z flap for back reconstruction after giant basal cell carcinoma resection: A case report and review of the literature. [PDF]

Int J Surg Case Rep, 2019
Torresetti M, Gioacchini M, Scalise A, Di Benedetto G.   +3 more
europepmc   +1 more source

Vacuum-assisted closure therapy after resection of giant basal cell carcinoma of the scalp. [PDF]

J Surg Case Rep, 2017
Pereira S, Malta W, Canha A, Polónia J.
europepmc   +1 more source

Comments on the giant basal cell carcinoma.

Anais brasileiros de dermatologia, 2014
Rafael, Denadai, Luís Ricardo Martinhão, Souto   +1 more
openaire   +1 more source

A Rare Case of Giant Basal Cell Carcinoma of the Abdominal Wall: Excision and Immediate Reconstruction with a Pedicled Deep Inferior Epigastric Artery Perforator (DIEP) Flap. [PDF]

Am J Case Rep, 2017
Di Lorenzo S, Zabbia G, Corradino B, Tripoli M, Pirrello R, Cordova A.   +5 more
europepmc   +1 more source

Giant Keratinocyte Carcinomas: Clinical, Histopathological, Molecular and Health-System Factors with Therapeutic Implications-A Structured Narrative Review. [PDF]

Cancers (Basel)
Ciborek A, Krauss H, Chęcińska-Maciejewska Z, Jaworek AK.   +3 more
europepmc   +1 more source

Giant neglected cutaneous squamous cell carcinoma of the scalp with full-thickness calvarial erosion and early fatal outcome: CT findings and treatment-planning implications. [PDF]

Radiol Case Rep
El Hassani N, Amar S, Jroundi L, El Aoufir O.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Giant polypoid basal cell carcinoma

Journal of Surgical Oncology, 1985
AbstractA giant polypoid basal cell carcinoma occurring in the back of a 64‐year‐old man is reported. Three other such cases from the English literature are reviewed.
D P Sarma, Deba P Sarma
exaly   +3 more sources

Sequential treatment of giant basal cell carcinomas

Journal of Plastic, Reconstructive and Aesthetic Surgery, 2009
Treatment of giant basal cell carcinomas (GBCC) can pose several challenges. In such instances, use of routine and recommended treatments for sporadic, average size basal cell carcinomas (BCC) is suboptimal, impractical and often leads to treatment failure.
J T Lear, V Madan, J T Lear
exaly   +3 more sources